Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
Phase 1
Completed
- Conditions
- Castration-resistant prostate cancer
- Registration Number
- JPRN-UMIN000002746
- Lead Sponsor
- Department of Urology Kinki University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Any of other cancers Infections (ex. HBV, HCV, HIV) Other serious disorders (ex. heart, lung, pulmonary, kidney, allergic diseases)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Toxicity evaluation.
- Secondary Outcome Measures
Name Time Method Immunological and clinical responses